DOI : 10.1055/s-00035024

Thrombosis and Haemostasis

Issue 05 · Volume 46 · 1981 DOI: 10.1055/s-008-40641


VIIIth International Congress on Thrombosis and Haemostasis
Toronto, 13.07 – 17.07.1981

Abstracts (HTML) List of Authors
1205
Ohshiro, T; Kosaki, G; Takaqi, K: Clinical Application Of Urokinase Treated Polymer For Antithrombogenic Medical Material
1206
Pavon, A Fernandez; Chacon, J L Fernandez; Cuesta, M V; Ruza, J: Treatment Of Neonatal Renal Vein Thrombosis (RVT) With Urokinase (UK)
1207
Trübestein, G; Brecht, Th; Ludwig, M; Brecht, G; Etzel, F: Urokinase Treatment In Acute And Subacute Deep Vein Thrombosis
1208
Zimmermann, R; Harenberg, J; Mörl, H; Rieben, F W; Götz, R: Urokinase Therapy Of Deep Vein Thrombosis Of The Lower Limb
1209
Schöffel, G; Zimmermann, R; Harenberg, J: Coagulation Changes Under An Effective Urokinase Dosage Regimen
1210
Zimmermann, R; Mörl, H; Harenberg, J; Brockhaus, W; Walter, E; Diehm, C: Urokinase Treatment Of Phlegmasia Cerulea Dolens
1211
Wijngaards, G; Kluft, C: Urokinase-Related Fibrinolytic Activity In Human Plasma
1212
Dubiel, M K; Scully, M F; Ham, R; Djazaeri, B; Kakkar, V V: Intermittent Infusions Of Arvin And Low-Dose Urokinase In The Treatment Of Deep Vein Thrombosis
1213
Musumeci, V; Zappacosta, B: Relevance Of Plasma alpha 2 Antiplasmin Measurement For Monitoring The Occurrence Of A Thrombolytic State During Urokinase Therapy. An In-Vitro Study
1214
Ogston, D: The Effect Of Alpha-Tocopherol On Urokinase
1215
Devine, E M; Shen, L L; Saldivar, A C; Gendrich, R L; Wiegand, R G; Holleman, W H: Rapid Analytical Techniques For Measuring The High And Low Molecular Weight Contents Of Urokinase Samples
1216
Camiolo, S M: Studies Of Mechanism Of The Augmentation Of Streptokinase (SK) Activator By Fibrinogen Or Fibrin
1217
Genth, K; Hofmann, M; Schaper, W: The Effect Of Streptokinase On Regional Myocardial Perfusion After Coronary Ligation In Dog
1218
Stenberg, B; Alpsten, M; Kjellström, T; Risberg, B: The Effect Of Tranexamic Acid On Experimental Gastric Haemorrhage
1219
Smith, R A G: Acyl-Enzymes As Fibrinolytic Agents
1220
Booth, N A; Bennett, B: Human Plasminogen Activator From Heart And Vascular Endothelium
1221
Stowell, V A; Mitchell, J E; Caprini, J A; Vagher, J P; Zuckerman, L: Local Versus Systemic Fibrinolytic Therapy
1222
Greaves, M; Preston, F E: The Fibrinolytic Response To Stanozolol In Normal Subjects
1223
Hansen, M Sandbjerg; Petersen, Lars Chr: Kinetic Characterization Of The Fast Acting Plasmin Inhibitor From Human Platelets
1224
Marsh, N A; Duffy, M J; Gaffney, P J: Plasminogen Activator Production By Malignant Human Cells: In Vivo And In Vitro Studies
1225
Yuen, P; Rwaan, H C: Fibrinolytic Activity In Metastatic Tumors And Tumor Thrombi
1226
Taberner, D A: Acquired α2 Antiplasmin Deficiency In Patients With Glomerular Proteinuria
1227
Egbring, R; Klingemann, H G; Heimburger, N; Karges, H E; Havemann, K: Hyperfibrinolysis In A Patient With IgG-Paraproteinemia
1228
Smokovitis, A; Maier, M; Binder, B R: Comparison Between Vascular Plasminogen Activator Activity And Blood Flow In The Renal Cortex After Induction Of Hemorrhagic Hypotension And Infusion Of Indomethacin Or Saralasin In Pigs
1229
Nieuwenhuizen, W; Vermond, A; Haverkate, F: Factors Influencing The Structure Of Terminal Plasmin Degradation Products Of Human Fibrinogen And Fibrin
1230
Stemberger, A; Haas, S; Stöhr, R; Blümel, G: Action Of Foy, A Polyvalent Synthetic Inhibitor On Coagulation And Fibrinolysis
1231
Dooijewaard, G; Kluft, C: The Estimation Of α2-Antiplasmin By Means Of Synthetic Substrates; Kinetic Analysis And Optimization Of The Method